resiquimod has been researched along with Infections, Orthomyxoviridae in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Johansson, C; Makris, S | 1 |
| Alexander-Miller, MA; Aycock, ST; Clemens, E; Gries, D; Hadimani, MB; Holbrook, BC; Jorgensen, MJ; King, SB; Machiele, E | 1 |
| Alexander-Miller, MA; Aycock, ST; Blevins, LK; D'Agostino, RB; Hadimani, MB; Holbrook, BC; Jorgensen, MJ; Kim, JR; King, SB; Kock, ND; Parks, GD | 1 |
3 other study(ies) available for resiquimod and Infections, Orthomyxoviridae
| Article | Year |
|---|---|
R848 or influenza virus can induce potent innate immune responses in the lungs of neonatal mice.
Topics: Adaptor Proteins, Vesicular Transport; Age Factors; Animals; Animals, Newborn; Cyclic AMP; Cytokines; Disease Models, Animal; Host-Pathogen Interactions; Imidazoles; Immunity, Innate; Lung; Macrophages, Alveolar; Mice; Myeloid Differentiation Factor 88; Orthomyxoviridae; Orthomyxoviridae Infections; Respiratory Syncytial Virus Infections; Signal Transduction | 2021 |
An R848 adjuvanted influenza vaccine promotes early activation of B cells in the draining lymph nodes of non-human primate neonates.
Topics: Adjuvants, Immunologic; Animals; Animals, Newborn; Antibodies, Viral; B-Lymphocytes; Chlorocebus aethiops; Dendritic Cells; Flagellin; Imidazoles; Influenza Vaccines; Lymph Nodes; Lymphocyte Activation; Orthomyxoviridae; Orthomyxoviridae Infections; Primates; Vaccination | 2018 |
A Novel R848-Conjugated Inactivated Influenza Virus Vaccine Is Efficacious and Safe in a Neonate Nonhuman Primate Model.
Topics: Animals; Animals, Newborn; Antibodies, Viral; Chlorocebus aethiops; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Enzyme-Linked Immunospot Assay; Flagellin; Imidazoles; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Orthomyxoviridae Infections; Toll-Like Receptor 7; Toll-Like Receptor 8; Vaccines, Inactivated | 2016 |